【24h】

Novel optical spectroscopy system for breast cancer diagnostics

机译:用于乳腺癌诊断的新型光谱系统

获取原文
获取原文并翻译 | 示例

摘要

We report on development of minimally invasive system for immediate diagnostics of breast cancer and on the results of its pilot clinical testing. The system designed by BioTelligent Inc is based on analysis of optical diffusion spectra (ODS) measured by a probe inserted into breast tissue during standard punch biopsy. Analysis of scattered spectra aimed to distinction of benign tumors from malignant ones is done by original procedure of data processing. Clinical testing of the created diagnostic system has been performed by classification of spectra collected from 146 patients with previously detected mammary neoplasms. The data of ODS study in each patient have been compared to the results of histology. The proposed technique has to date demonstrated sensitivity of 96%, specificity of 80% and diagnostic accuracy of 88%. These values are expected to improve as the data sets continue to grow and more sophisticated data processing is employed.
机译:我们报告了用于乳腺癌的即时诊断的微创系统的发展以及其中试临床测试的结果。由BioTelligent Inc设计的系统基于对光学扩散光谱(ODS)的分析,该光谱是通过在标准打孔活检期间插入乳房组织的探针测量的。旨在区分良性肿瘤与恶性肿瘤的散射光谱的分析是通过原始的数据处理程序进行的。通过对从146例先前发现的乳腺肿瘤患者中收集的光谱进行分类,对所创建的诊断系统进行了临床测试。将每位患者的ODS研究数据与组织学结果进行了比较。迄今为止,所提出的技术已证明灵敏度为96%,特异性为80%,诊断准确性为88%。随着数据集的不断增长和采用更复杂的数据处理,这些值有望提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号